News | May 05, 2026
Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy
Enterprise-scale adoption in 2026 will be driven by domain-specific AI, compliance automation, and strong digital foundations across quality, manufacturing and regulatory workflows
Precision medicine company advances Raman spectroscopy-based therapeutic drug monitoring platform for rapid, patient-specific dosing solutions
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
Approval for generic Ozempic® in Canada strengthens OneSource’s global CDMO footprint in complex peptide injectable manufacturing
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
Subscribe To Our Newsletter & Stay Updated
